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initiation of heparin anticoagulation before
treatment with factor concentrates in bleed-
ing patients under ECC is controversial,
because the effect of heparin is antithrom-
bin dependent. We recommend the close
monitoring and substitution of antithrom-
bin in conditions with an ongoing activa-
tion of the hemostatic system. Although
there is no evidence from the literature yet,
inhibitor levels (in particular antithrombin)
should be kept within the normal range
before administration of factor concen-
trates to attenuate the procoagulant re-
sponse, possibly resulting in thromboem-
bolic complications.
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Is there an evidence in favor of off-
pump coronary artery bypass?
To the Editor:
We read with interest the report of Mack
and colleagues1 that shows “improved out-
come in coronary artery bypass grafting
with beating-heart techniques.” In the era
of evidence-based medicine and megatri-
als, class A level evidence will remain the
standard tool that forces change of direc-
tion of currently applied surgical proce-
dures, including coronary artery bypass
grafting. We concede that in the absence of
major prospective randomized trials2,3 ret-
rospective studies such as this may contrib-
ute enough evidence to sway the balance in
favor of or against off-pump coronary ar-
tery bypass grafting (OPCAB).
However, we wish to highlight two is-
sues that could have a significant impact on
the conclusions derived from the study.
First, at one point the authors claimed that
the conversion rate was 2.9% and stated
that “these patients were analyzed with the
on-pump group.” Later, however, they re-
ported a conversion rate of 1.6% and sug-
gested that the analysis was performed on
an intent-to-treat basis (that conversions
were analyzed with the OPCAB group).
These conflicting statements require further
clarification. Second, the need for a sub-
group analysis of the cases converted from
OPCAB to an on-pump procedure cannot
be overemphasized. This analysis may pro-
vide the answer to a number of important
questions regarding OPCAB, such as indi-
cations, timing, predictors, and, more im-
portantly, the outcome of conversion in
terms of mortality and morbidity.
Reida Menshawe El Oakley, MD, FRCS
Oon Cheong Ooi, AFRCS
Chuen Neng Lee, FRCS
Department of Cardiac, Thoracic, and
Vascular Surgery
The Heart Institute
National University Hospital
Singapore, Singapore
References
1. Mack M, Bachand D, Acuff T, Edgerton J,
Prince S, Dewey T, et al. Improved outcomes
in coronary artery bypass grafting with beat-
ing-heart techniques. J Thorac Cardiovasc
Surg. 2002;124:598-607.
2. Yacoub M. Off-pump coronary bypass sur-
gery: in search of an identity. Circulation.
2001;104:1743-5.
3. van Dijk D, Nierich AP, Jansen EW, Nathoe
HM, Suyker WJ, Diephuis JC, et al. Early
outcome after off-pump versus on-pump cor-
onary bypass surgery: results from a random-
ized study. Circulation. 2001;104:1761-6.
doi:10.1067/S0022-5223(03)01199-1
Short esophagi and a long career
To the Editor:
Professor J. Leigh Collis, a prominent sur-
geon, made several contributions to the de-
velopment of the thoracic and cardiac sur-
gery. However, he was immortalized and
known worldwide for his work on gastro-
plasty, originally published in this Journal
46 years ago.1
I contacted by letter the then-90-year-
old Professor Collis, asking for data to be
used in an article concerning the history of
esophageal surgery. I was honored with a
concerned and pleasant reply. After our last
contact, however, I received the grievous
notice that Professor Collis had died on
February 4, 2003.
It is fitting to pay homage to this singu-
lar character in the history of the esopha-
geal surgery in the same Journal that im-
mortalized him.
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Problems with complication rate
analysis
To the Editor:
In a recent issue of this Journal, Grunk-
emeier and Wu1 analyzed complication
rates after bileaflet valve implantation by
means of pooled data and regression anal-
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